Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 4/14/2017
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / -||UN / UN|
Administered by: Other Purchased by: Unknown
Symptoms: Appendicitis perforated, Fatigue, Headache, Tachycardia, Postural orthostatic tachycardia syndrome, Complex regional pain syndrome, Weight bearing difficulty
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Diagnostic Lab Data:
CDC 'Split Type': GB0095075131612GBR013259
Write-up:This spontaneous report was received from a consumer via the Agency (case report number GB-MHRA-EYC 00150652) referring to a 12 year old female patient. On an unspecified date in 2011, the patient was vaccinated with unknown dose number of GARDASIL, 3 DF, parenteral. On an unspecified date in 2011, the patient experienced burst appendix, complex regional pain syndrome, postural orthostatic tachycardia syndrome (POTS) symptoms, tachycardia, headache, chronic fatigue and unable to weight bear on either leg. The outcome of complex regional pain syndrome, weight bearing difficulty, tachycardia, appendicitis perforated, fatigue and headache was reported as not recovered. The relationship between adverse events and therapy was not provided. Additional information is not expected as no follow up can be obtained from the Agency.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166